To include your compound in the COVID-19 Resource Center, submit it here.

Aurograb: Phase IIb

In a Phase IIb study in 9 patients, 1 mg/kg of Aurograb twice daily

Read the full 142 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE